Analyst consensus rating
HCA Healthcare Analyst Rating: Buy
Direct answer
HCA Healthcare's consensus rating is Buy.
22 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $460.59.
Forecast evidence checked October 18, 2026.
Get free HCA Healthcare email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $458.84
- Average price target
- $460.59
- High price target
- $579.00
- Low price target
- $380.00
- Low target gap
- -17.2%
- Target upside
- +0.4%
- High target gap
- +26.2%
- Target range width
- 43.4%
- Consensus rating
- Buy
- Analysts
- 22
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for HCA Healthcare?
HCA Healthcare has a verified Buy consensus. The same dataset has an average price target of $460.59.
How far are HCA Healthcare's low and high targets from the recorded price?
The low target implies -17.2%, while the high target implies +26.2%.
How many analysts are included in HCA Healthcare's consensus?
The verified consensus includes 22 analysts.
How is HCA Healthcare's target upside or downside calculated?
The average target of $460.59 is divided by the recorded price of $458.84, then one is subtracted to produce +0.4%. This does not guarantee a future return.
When was HCA Healthcare's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.